Understand Folic Acid Deficiency Anemia, also known as Folate Deficiency Anemia or Vitamin B9 Deficiency Anemia. This resource provides information on diagnosis, clinical documentation, and medical coding for healthcare professionals. Learn about symptoms, causes, and treatment of Folate Deficiency Anemia and ensure accurate medical coding for Vitamin B9 Deficiency Anemia in clinical settings.
Also known as
Nutritional folate deficiency anemia
Anemia caused by insufficient dietary folate intake.
Drug-induced folate deficiency anemia
Anemia due to medication interfering with folate metabolism.
Folate deficiency anemia, unspecified
Anemia from folate deficiency without a specific cause identified.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the anemia due to dietary folate deficiency?
When to use each related code
| Description |
|---|
| Low folate levels cause anemia. |
| Low vitamin B12 causes anemia. |
| Anemia from iron deficiency. |
Coding as unspecified anemia (e.g., D64.9) when clinical documentation supports folic acid deficiency anemia (D52.0).
Miscoding as B12 deficiency anemia (D51.0) due to similar symptoms, requiring clear documentation differentiating B9 and B12 deficiencies.
Failing to document the underlying cause (e.g., dietary deficiency) of folic acid deficiency anemia, impacting accurate coding and severity reflection.
Q: What are the key differentiating factors in diagnosing folate deficiency anemia versus vitamin B12 deficiency anemia, considering both present with megaloblastic changes?
A: While both folate and vitamin B12 deficiencies cause megaloblastic anemia, distinguishing between them is crucial for effective treatment. Neurological symptoms, such as peripheral neuropathy and cognitive impairment, are typically present in B12 deficiency but absent in folate deficiency. Furthermore, serum methylmalonic acid (MMA) levels are elevated in B12 deficiency but normal in folate deficiency. Homocysteine levels are elevated in both conditions. Accurate diagnosis relies on measuring serum folate, vitamin B12, MMA, and homocysteine levels. Consider implementing a diagnostic algorithm that incorporates these markers to ensure accurate differentiation and avoid misdiagnosis. Explore how MMA and homocysteine testing can improve diagnostic accuracy in challenging cases.
Q: How does folic acid deficiency anemia impact pregnant patients, and what are the recommended preventative measures and treatment protocols during pregnancy?
A: Folic acid deficiency anemia during pregnancy poses significant risks to both the mother and the developing fetus, including neural tube defects, preterm birth, and low birth weight. Pregnant patients have increased folate requirements, making them more susceptible to deficiency. The recommended preventative measure is folic acid supplementation, typically starting before conception and continuing throughout pregnancy. The CDC recommends 400 mcg of folic acid daily for women of childbearing age. For women with a history of neural tube defects, a higher dose of 4 mg daily is recommended. Treatment for folic acid deficiency anemia during pregnancy involves higher doses of folic acid, usually 1 mg daily. Learn more about the specific folic acid supplementation guidelines for pregnant patients with risk factors such as obesity or malabsorption syndromes.
Patient presents with symptoms suggestive of folic acid deficiency anemia, including fatigue, weakness, pallor, shortness of breath, palpitations, and glossitis. The patient reports a dietary history low in folate-rich foods such as leafy green vegetables, citrus fruits, and fortified grains. Macrocytic anemia was noted on complete blood count (CBC) with elevated mean corpuscular volume (MCV). Peripheral blood smear revealed megaloblastic changes. Serum folate levels were measured and found to be below the normal range, confirming the diagnosis of folate deficiency anemia. Differential diagnosis included vitamin B12 deficiency anemia, which was ruled out with normal serum B12 levels. Other potential causes of macrocytic anemia such as myelodysplastic syndrome and drug-induced macrocytosis were also considered and deemed less likely based on the clinical picture and laboratory findings. Treatment plan includes oral folic acid supplementation at 1 mg daily. Patient education was provided regarding dietary sources of folate and the importance of medication adherence. Follow-up CBC and serum folate levels will be assessed to monitor response to therapy. ICD-10 code D52.0 (Folic acid deficiency anemia) is documented for this encounter. Patient was counseled on the signs and symptoms of anemia and advised to return for follow-up care as scheduled.